On the very day President Duma Boko signed an agreement to waive Botswana’s post-importation testing of medicines from India, tens of Botswana tuberculosis (TB) patients were suffering treatment failures due to substandard drugs from India.
On 13th November President Boko signed an agreement with the visiting President Droupadi Murmu of India, to adopt the Indian Pharmacopoeia (IP) as a reference standard for medicines imported into Botswana, a move that eliminate duplicate post-importation testing and streamlines approval for Indian drugs entering the country.
There's more to this story
But to keep reading, we need you to subscribe.
Investigative journalism is an indispensable part of a healthy society, but it's also expensive to produce. We are reliant on subscriptions to fund our work, and while you can enjoy most of our stories for free, a small number of premium features are reserved for subscribers.
You can subscribe for one week, a month or a full year - the choice is yours.
Save 77% on an annual subscription. Click here to find out how.
Existing subscribers can log in to keep reading here.
